Document is current
Any future updates will be listed below
-
Authors
Kikuchi, Taku https://orcid.org/0000-0002-3210-7756
Tsukada, Nobuhiro
Nomura, Moe
Kasuya, Yuki
Oda, Yuki
Sato, Kota
Takei, Tomomi
Ogura, Mizuki
Abe, Yu
Suzuki, Kenshi
Ishida, Tadao
- License Information
-
More Information
Article History
Received: 21 February 2023
Accepted: 6 April 2023
First Online: 28 April 2023
Declarations
:
: The study was approved by the JRCMC Institutional Review Board to be conducted under an abbreviated informed consent procedure and an opt-out consent principle. None of the included participants requested to be removed from the study.
: TK has received personal fees from Janssen, Takeda, and Sanofi. NT has received personal fees from Janssen and Sanofi. TI received honoraria from Ono, Takeda, Celgene/Bristol-Myers Squibb, and Janssen. KS has received honoraria from Takeda, Celgene, Ono, Amgen, Novartis, Sanofi, BMS, AbbVie, and Janssen; consultancy fees from Takeda, Amgen, Janssen, and Celgene; and research funding from BMS, Celgene, and Amgen. The remaining authors declare no competing financial interests.
